Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2016 February;68(1) > Minerva Urologica e Nefrologica 2016 February;68(1):14-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEW  UROLOGY


Minerva Urologica e Nefrologica 2016 February;68(1):14-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Focus on desmopressin and enuresis: a review of literature

Pietro FERRARA 1, Flaminia VENA 2, Maria C. BASILE 2, Francesca IANNIELLO 1, Antonio GATTO 1

1 Institute of Pediatrics, Sacro Cuore Catholic University, Rome, Italy; 2 Campus Bio-Medico University, Rome, Italy


PDF  


Nocturnal enuresis (NE) is a common disorder in children. Choice of treatment depends on the frequency and severity of symptoms, the child’s age and motivation. Treatment options for NE are alarm, desmopressin and imipramine. In particular, the main desmopressin therapeutical effect is the antidiuretic activity. The different formulations of desmopressin are an injectable solution, an oral tablet formulation and the recent oral lyophilisate (MELT). MELT with its higher biodisponibility guarantees the same therapy response of other formulations with a lower doses and it represents the first line and safety treatment for the NE.

top of page

Publication History

Cite this article as

Ferrara P, Vena F, Basile MC, Ianniello F, Gatto A. Focus on desmopressin and enuresis: a review of literature. Minerva Urol Nefrol 2016 February;68(1):14-9. 

Corresponding author e-mail

pferrara@rm.unicatt.it